Virus-only testing may miss pneumonia-associated bacterial co-detections in 78% of virus-positive cases, while bacteria-only testing may miss viral co-detections in 88% of cases positive for pneumonia ...

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today highlighted its portfolio of molecular testing solutions ...

EVANSTON, Ill.--(BUSINESS WIRE)--Minute Molecular Diagnostics today announced that the U.S. Food and Drug Administration (FDA) granted an Emergency Use Authorization (EUA) for its rapid DASH ...

Since the start of the COVID-19 pandemic in the United States, over 46 million positive coronavirus test results have been reported to the U.S. Centers for Disease Control and Prevention (CDC). When ...

Testing only for viruses such as influenza or COVID-19 when diagnosing respiratory infections can cause clinicians to miss a significant share of bacterial co-i ...

Many people will have experienced being unwell with an unknown infection and having to undergo multiple tests to determine the culprit. This sequential process of elimination can be time-consuming and ...

Researchers at Dartmouth Hitchcock Medical Center have developed a way to diagnose Lyme disease earlier and more accurately than traditional testing methods. Over the past 30 years, Lyme disease has ...

Arthropod-borne diseases such as Dengue, Chikungunya, Malaria (caused by Plasmodium spp.), and Zika are endemic and re-emerging infections in tropical and subtropical regions. During heavy monsoon ...

Antibody testing shows whether you've had the COVID-19 virus in the past. It's not the same as testing to see whether you have the virus now.

The hepatitis testing market presents significant opportunities driven by rising hepatitis infections, increasing demand for early diagnosis, and advancements in rapid point-of-care testing. Key ...

(Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the ...